Back

ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

29 August 2016 (11:54 - 12:04)
Organised by:
Congress Presentation Part of: Hot Line prevention and lipids Lipids ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Patrick Moriarty

University of Kansas Medical Center, Kansas City (United States of America)

14 More presentations in this session

Presentation thumbnail
HIJ-PROPER - LDL cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidemia
Professor N. Hagiwara (Tokyo, JP)
Slides Video
Presentation thumbnail
HIJ-PROPER - Discussant review.
Professor S. Gielen (Detmold, DE)
Slides Video
Presentation thumbnail
HIJ-PROPER - Panel discussion.
Video
Presentation thumbnail
OPTICARE - Benefits of the OPTImal CArdiac REhabilitation trial: a randomized, controlled superiority trial of an expanded educational and behavioral intervention
Doctor R. Van Domburg (Rotterdam, NL)
Slides Video
Presentation thumbnail
OPTICARE - Discussant review.
Professor A. Abreu (Lisbon, PT)
Slides Video

Access the full session

Session thumbnail
Hot Line prevention and lipids

The Event

Event poster

ESC Congress 2016

29 August 2016 11:54 CET
You may be interested in
thumbnail
Congress Presentation
2 September 2019
thumbnail
Congress Presentation
Targeting Lp(a): therapeutic insights and novel developments.
28 August 2022
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025
thumbnail
Congress Presentation
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources